Cargando…

Cancer in corona times

Humanity is witnessing an unprecedented tsunami of corona virus disease 2019 (COVID-19) patients. Till date, India houses 10,453 confirmed COVID-19 patients with a death toll of 358 nationwide and the number is steadily rising with each passing day. The capital city of Delhi, harbouring 1510 patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Shagun Bhatia, Chawla, Rajiv
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796732/
https://www.ncbi.nlm.nih.gov/pubmed/33447194
http://dx.doi.org/10.4103/sja.SJA_317_20
_version_ 1783634743321952256
author Shah, Shagun Bhatia
Chawla, Rajiv
author_facet Shah, Shagun Bhatia
Chawla, Rajiv
author_sort Shah, Shagun Bhatia
collection PubMed
description Humanity is witnessing an unprecedented tsunami of corona virus disease 2019 (COVID-19) patients. Till date, India houses 10,453 confirmed COVID-19 patients with a death toll of 358 nationwide and the number is steadily rising with each passing day. The capital city of Delhi, harbouring 1510 patients, has the dubious distinction of being the second largest hotspot for COVID positive patients in India, second only to the state of Maharashtra. Being immuno-compromised, cancer patients are first more susceptible to catch this virus and secondly may witness a more devastating course. Having cancer is a bigger risk factor for contracting COVID-19 than even old age. “Death due to untreated cancer is a much bigger reality than death due to COVID-19,” is one perspective that advocates continuation of cancer therapy in corona times albeit by converting cancer hospitals into virtual corona-free fortresses with several tiers of barriers against corona. The immediate, short and long term implications of the corona pandemic and a nationwide lockdown to curtail it, on cancer patients and their caregivers is discussed at length here tempered with experience from the largest tertiary care oncology setup of Northern India. Rigorous literature review based on Medline, Google scholar, Embase, Cochrane and Scopus database search was utilized.
format Online
Article
Text
id pubmed-7796732
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-77967322021-01-13 Cancer in corona times Shah, Shagun Bhatia Chawla, Rajiv Saudi J Anaesth Review Article Humanity is witnessing an unprecedented tsunami of corona virus disease 2019 (COVID-19) patients. Till date, India houses 10,453 confirmed COVID-19 patients with a death toll of 358 nationwide and the number is steadily rising with each passing day. The capital city of Delhi, harbouring 1510 patients, has the dubious distinction of being the second largest hotspot for COVID positive patients in India, second only to the state of Maharashtra. Being immuno-compromised, cancer patients are first more susceptible to catch this virus and secondly may witness a more devastating course. Having cancer is a bigger risk factor for contracting COVID-19 than even old age. “Death due to untreated cancer is a much bigger reality than death due to COVID-19,” is one perspective that advocates continuation of cancer therapy in corona times albeit by converting cancer hospitals into virtual corona-free fortresses with several tiers of barriers against corona. The immediate, short and long term implications of the corona pandemic and a nationwide lockdown to curtail it, on cancer patients and their caregivers is discussed at length here tempered with experience from the largest tertiary care oncology setup of Northern India. Rigorous literature review based on Medline, Google scholar, Embase, Cochrane and Scopus database search was utilized. Wolters Kluwer - Medknow 2020 2020-09-24 /pmc/articles/PMC7796732/ /pubmed/33447194 http://dx.doi.org/10.4103/sja.SJA_317_20 Text en Copyright: © 2020 Saudi Journal of Anesthesia http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Review Article
Shah, Shagun Bhatia
Chawla, Rajiv
Cancer in corona times
title Cancer in corona times
title_full Cancer in corona times
title_fullStr Cancer in corona times
title_full_unstemmed Cancer in corona times
title_short Cancer in corona times
title_sort cancer in corona times
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796732/
https://www.ncbi.nlm.nih.gov/pubmed/33447194
http://dx.doi.org/10.4103/sja.SJA_317_20
work_keys_str_mv AT shahshagunbhatia cancerincoronatimes
AT chawlarajiv cancerincoronatimes